References
Coley WB (1910) The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the bacillus prodigiosus). Proc R Soc Med. 3(Surg Sect):1–48.
Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348:62–8.
Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271:1734–6.
Iwai Y, Terawaki S, Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol. 2005;17:133–44.
Zacharakis N, Chinnasamy H, Black M, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724–30.
Pham T, Roth S, Kong J, et al. An update on immunotherapy for solid tumors: a review. Ann Surg Oncol. 2018;25:3404–12.
Kong J, Guerra G, Millen R, et al. Tumor infiltrating lymphocyte function predicts response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. JCO Precis Oncol. 2018. https://doi.org/10.1200/PO.18.00075.
Cross RS, Malaterre J, Davenport AJ, et al. Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein. Clin Transl Immunol. 2015;4:e30.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflicts of interest to disclose.
Additional information
ASO Author Reflections offer a brief invited commentary on the article, “An Update on Immunotherapy for Solid Tumors: A Review”. Ann Surg Oncol. 2018;25:3404–12.
Rights and permissions
About this article
Cite this article
Pham, T., Roth, S., Desai, J. et al. ASO Author Reflections: Immunotherapy for Solid Tumors: A Review. Ann Surg Oncol 25 (Suppl 3), 974–975 (2018). https://doi.org/10.1245/s10434-018-6966-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6966-8